- Active not recruitingPHASE1, PHASE2
IMGN632 as Monotherapy or With Venetoclax and/or Azacitidine for Participants With CD123-Positive Acute Myeloid Leukemia
This study is testing a new drug, IMGN632, for adults with a type of blood cancer called Acute Myeloid Leukemia (AML). It's looking at whether IMGN632 is safe and effective when given alone or with other common AML treatments.
For: Acute Myeloid LeukemiaUnited States · France · Germany - Active not recruitingPHASE1, PHASE2
Study of IMGN632 in Patients With Untreated BPDCN and Relapsed/Refractory BPDCN
This study is testing a new medicine called IMGN632 for people with certain types of blood cancers, including a rare one called BPDCN. We're looking at how safe it is, how well it's tolerated, and if it helps fight the cancer.
For: Blastic Plasmacytoid Dendritic Cell Neoplasm · Myeloproliferative NeoplasmUnited States · France · Germany